Our Therapy Areas
Cardiovascular trials
FutureMeds are equipped to run a range of Cardiovascular trials to evaluate the safety, efficacy, and outcomes of treatments or interventions for cardiovascular diseases. Our investigators have a wealth of experience in Cardiovascular trials for conditions like heart attacks, heart failure, hypertension, arrhythmias, and strokes.
ASCVD
ASCVD is a leading cause of morbidity and mortality worldwide and is primarily associated with the narrowing or blockage of arteries due to the accumulation of fatty deposits (plaques), which consist of cholesterol, calcium, and other substances. Our PIs have experience in the specific challenges of these trials to ensure high patient retention and quality data.
11 experienced FutureMeds Investigators
CVOTs
CVOTs are essential for determining the cardiovascular safety and efficacy of new therapies, especially those intended for patients with existing cardiovascular risk factors or conditions like diabetes. Our site teams have the experts, experience and equipment to deliver high quality CVOTs.
5 experienced FutureMeds Investigators
Dyslipidemia
Dyslipidemia is characterized by abnormal levels of lipids (fats) in the blood. These lipids include cholesterol and triglycerides, which are essential for various bodily functions but can cause health problems when present in abnormal amounts. Our experts have experience in conducting Dyslipidemia trials across Europe.
13 experienced FutureMeds Investigators
Hypertension
Hypertension is where the force of the blood against the walls of the arteries is consistently too high. Over time, this increased pressure can cause health problems, particularly cardiovascular disease. Our experienced teams have conducted multiple trials across Europe to give patients access to the latest innovative treatments.
25 experienced FutureMeds Investigators
Atrial Fibrillation
Atrial fibrillation (AFib) is a common heart rhythm disorder characterized by an irregular and often rapid heartbeat. It occurs when the upper chambers of the heart, known as the atria, beat out of sync with the lower chambers, the ventricles. Our PIs have experience in the specific challenges of these trials to ensure high patient retention and quality data.
18 experienced FutureMeds Investigators
Heart Failure
Heart failure is a chronic medical condition where the heart is unable to pump blood efficiently enough to meet the body's needs. As a result, organs and tissues may not receive enough oxygen and nutrients, leading to various symptoms and complications. Our site teams have the experts, experience and equipment to deliver high performing Heart Failure trials.
19 experienced FutureMeds Investigators
Hypercholesterolemia
Hypercholesterolemia is a medical condition characterized by elevated levels of cholesterol in the blood. Excessive cholesterol, particularly low-density lipoprotein (LDL) cholesterol, can lead to the development of atherosclerosis, where plaques build up in the arteries, increasing the risk of cardiovascular diseases such as heart attacks and strokes. Our experts have experience in conducting Hypercholesterolemia trials across Europe.
9 experienced FutureMeds Investigators
“Cardiovascular disease remains one of the leading causes of mortality worldwide, making research in this therapeutic area not just important, but essential. With every study we conduct, we edge closer to breakthroughs that can save lives, improve patient outcomes, and offer hope to those affected. For a seasoned researcher this dedication is fuelled by a relentless pursuit of knowledge and a deep responsibility to advance medical science for my beloved patients - my life.”